| Literature DB >> 28959220 |
Richard J Servatius1,2,3, Justin D Handy1,3, Michael J Doria4, Catherine E Myers5,6, Christine E Marx7,8, Robert Lipsky9, Nora Ko3,10, Pelin Avcu3,10, W Geoffrey Wright11, Jack W Tsao12,13,14.
Abstract
U.S. Coast Guard (CG) personnel face occupational stressors (e.g., search and rescue) which compound daily life stressors encountered by civilians. However, the degree CG personnel express stress-related mental health symptoms of posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) is understudied as a military branch, and little is known concerning the interplay of vulnerabilities and neurocognitive outcomes in CG personnel. The current study addressed this knowledge gap, recruiting 241 active duty CG personnel (22% female) to assess mental health, personality, and neurocognitive function. Participants completed a battery of scales: PTSD Checklist with military and non-military prompts to screen for PTSD, Psychological Health Questionnaire 8 for MDD, and scales for behaviorally inhibited (BI) temperament, and distressed (Type D) personality. Neurocognitive performance was assessed with the Defense Automated Neurobehavioral Assessment (DANA) battery. Cluster scoring yielded an overall rate of PTSD of 15% (95% CI: 11-20%) and 8% (95% CI: 3-9%) for MDD. Non-military trauma was endorsed twice that of military trauma in those meeting criteria for PTSD. Individual vulnerabilities were predictive of stress-related mental health symptoms in active duty military personnel; specifically, BI temperament predicted PTSD whereas gender and Type D personality predicted MDD. Stress-related mental health symptoms were also associated with poorer reaction time and response inhibition. These results suggest rates of PTSD and MDD are comparable among CG personnel serving Boat Stations to those of larger military services after combat deployment. Further, vulnerabilities distinguished between PTSD and MDD, which have a high degree of co-occurrence in military samples. To what degree stress-related mental healthy symptoms and attendant neurocognitive deficits affect operational effectiveness remains unknown and warrant future study.Entities:
Keywords: PTSD; depression; military personnel; personality; temperament
Year: 2017 PMID: 28959220 PMCID: PMC5603677 DOI: 10.3389/fpsyg.2017.01513
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Demographic characteristics of the CG sample.
| < 25 years | 74 (31%) | 43 (23%) | 31 (60%) | |
| 25–29 years | 82 (34%) | 66 (35%) | 16 (31%) | |
| >29 years | 85 (35%) | 80 (42%) | 5 (9%) | |
| White/Non-Hispanic | 176 (73%) | 140 (74%) | 36 (69%) | |
| Black/Non-Hispanic | 8 (3%) | 7 (4%) | 1 (2%) | |
| Hispanic | 35 (15%) | 25 (13%) | 10 (19%) | |
| Other | 22 (9%) | 17 (9%) | 5 (10%) | |
| Some college or less | 197 (82%) | 157 (83%) | 40 (77%) | |
| Bachelor's or higher | 44 (18%) | 32 (17%) | 12 (23%) | |
| One | 70 (30%) | 64 (34%) | 6 (12%) | |
| More than one | 42 (18%) | 37 (20%) | 5 (10%) | |
| Cadet | 7 (3%) | 3 (2%) | 4 (8%) | |
| Junior Enlisted (E1–E4) | 119 (50%) | 78 (42%) | 41 (80%) | |
| NCO (E5–E6) | 91 (39%) | 86 (46%) | 5 (10%) | |
| Senior NCO (E7–E9) | 12 (5%) | 12 (6%) | 0 | |
| Officer | 7 (3%) | 6 (3%) | 1 (2%) | |
| Previously Deployed | 104 (45%) | 94 (51%) | 10 (20%) | |
| Poor Sleep Quality | 118 (56%) | 85 (52%) | 33 (70%) | |
| Yes | 20 (9%) | 19 (11%) | 1 (2%) | |
| Type D | 58 (24%) | 43 (23%) | 15 (29%) | |
| Inhibited | 80 (33%) | 62 (33%) | 19 (37%) |
Reliability and interrelatedness of scales.
| 1 PCL-M | – | ||||
| 2 PCL-NM | 0.69 | – | |||
| 3 PHQ-8 | 0.70 | 0.64 | – | ||
| 4 DS14 | 0.49 | 0.56 | 0.61 | – | |
| 5 AMBI | 0.37 | 0.43 | 0.33 | 0.51 | – |
| Mean | 25.71 | 28.95 | 4.80 | 19.53 | 14.17 |
| St.Dev | 9.83 | 11.65 | 4.67 | 8.62 | 5.69 |
| Range | 17–69 | 17–66 | 0–20 | 3–46 | 3–30 |
| Chronbach's α | 0.92 | 0.93 | 0.87 | 0.89 | 0.83 |
PCL-M, PTSD Checklist Military; PCL-NM, PTSD Checklist Non-Military; PHQ, Personal Health Questionnaire; DS14, Type D Scale; AMBI, Adult Measure of Behavioral Inhibition;
p < 0.01.
Rates of subclinical and PTSD Based on PCL-M and PCL-NM.
| 168 | 23 | 15 | 206/241 (85%) | ||
| 7 | 6 | 7 | 20/241 (8%) | ||
| 3 | 2 | 10 | 15/241 (7%) | ||
| 178/241 (74%) | 31/241 (13%) | 32/241 (13%) | 241 | ||
PCL-M, PTSD Checklist Military; PCL-NM, PTSD Checklist Non-Military.
Predictors of subclinical and clinical PTSD based on multinomial logistic regression.
| −0.06 (0.04) | 0.94 | 0.86–1.02 | −1.93 (1.28) | 0.95 | 0.87–1.03 | 0.06 (0.03) | 1.06 | 0.99–1.14 | −0.02 (0.06) | 0.98 | 0.88–1.10 | |
| Female | 0.14 (0.53) | 1.15 | 0.41–3.25 | −0.88 (0.60) | 0.42 | 0.13–1.36 | 1.11 (0.47) | 3.04 | 1.21–7.62 | 1.81 (0.65) | 6.12 | 1.70–21.95 |
| Male (ref) | ||||||||||||
| One | −0.80 (0.55) | 0.92 | 0.32–2.69 | −0.65 (0.61) | 0.52 | 0.16–1.74 | −1.05 (0.50) | 0.35 | 0.13–0.93 | 0.43 (0.68) | 1.54 | 0.41–5.84 |
| More Than One | 0.42 (0.58) | 1.51 | 0.49–4.70 | −0.18 (0.61) | 0.83 | 0.25–2.72 | −0.58 (0.53) | 0.56 | 0.20–1.58 | 0.69 (0.71) | 1.99 | 0.49–8.06 |
| None (ref) | ||||||||||||
| Yes | −0.94 (1.13) | 0.39 | 0.04–3.58 | 0.57 (0.73) | 1.76 | 0.42–7.34 | 0.18 (0.78) | 1.19 | 0.26–5.44 | 1.85 (0.87) | 6.38 | 1.17–34.91 |
| No (ref) | ||||||||||||
| Type D | −0.51 (0.58) | 0.60 | 0.19–1.88 | −0.19 (0.57) | 0.82 | 0.27–2.52 | 2.26 (0.52) | 9.56 | 3.46–26.40 | 2.38 (0.69) | 10.81 | 2.78–41.98 |
| Non-Type D (ref) | ||||||||||||
| Inhibited | 1.23 (0.50) | 3.41 | 1.28–9.09 | 1.51 (0.53) | 4.54 | 1.62–12.76 | −0.21 (0.47) | 0.81 | 0.32–2.04 | −0.57 (0.69) | 0.56 | 0.15–2.16 |
| Non-Inhibited (ref) | ||||||||||||
| 0.22 (0.06) | 1.25 | 1.11–1.41 | 0.31 (0.06) | 1.37 | 1.21–1.54 | |||||||
| 0.09 (0.02) | 1.09 | 1.05–1.14 | 0.16 (0.03) | 1.17 | 1.11–1.23 | |||||||
| | 0.32 | 0.45 | ||||||||||
| | ||||||||||||
B, Logistic coefficient; SE, standard error; OR, odds ratio; CI, confidence interval; R2CS, Cox and Snell R2; ref, reference category; PHQ, Personal Health Questionnaire; PCL, PTSD Checklist; BI, Behavioral Inhibition. Significance levels:
p < 0.05,
p < 0.01.
Means, standard deviations, and discriminant function coefficients for symptom groups on neurocognitive assessments.
| SRT1 TP | 185.88 (24.96) | 172.62 (24.08) | 178.72 (33.44) | 180.66 (28.74) | −0.418 |
| SRT2 TP | 189.87 (25.16) | 179.07 (25.02) | 184.06 (24.54) | 170.95 (28.84) | 0.533 |
| CS-L TP | 44.38 (9.03) | 43.96 (6.45) | 43.68 (8.98) | 41.36 (8.07) | 0.021 |
| CS-R TP | 47.08 (13.88) | 47.35 (9.11) | 47.52 (12.43) | 43.52 (11.51) | 0.145 |
| PRT TP | 97.31 (13.60) | 98.03 (14.03) | 95.84 (12.67) | 91.36 (15.13) | 0.105 |
| SPD TP | 29.87 (6.98) | 30.04 (6.24) | 29.96 (6.02) | 30.27 (6.33) | −0.430 |
| GNG TP | 118.77 (16.33) | 117.85 (14.46) | 115.28 (13.02) | 105.47 (18.36) | 0.741 |
| MTS TP | 32.40 (8.24) | 28.70 (7.50) | 31.60 (8.94) | 29.86 (8.43) | 0.220 |
| SMS TP | 54.70 (17.18) | 47.89 (18.82) | 55.65 (20.17) | 51.36 (19.50) | −0.273 |
TP, Throughput; SRT1, Simple Reaction Time 1; SRT2, Simple Reaction Time 2; CS-L, Code Substitution Learning; CS-R, Code Substitution Recall; PRT, Procedural Reaction Time; SPD, Spatial Discrimination; GNG, Go/No-Go; MTS, Match to Sample; SMS, Sternberg Memory Search. ws, standardized discriminant function coefficient. Values represent average TP scores and standard deviations.